Since IL-17C and IL-17RE are expressed in the skin and have been shown to be pathogenic in mouse models of dermal inflammation [23, 29], we hypothesized that the most likely setting in which the IL-17C/IL-17RE axis might participate in antifungal immunity would be in cutaneous C. albicans infections. The gene discussed is IL17C; the disease is inflammation.